Arrowhead Pharmaceuticals, Inc.

WELLS FARGO & COMPANY/MN ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

152,507

Value ($000)

10,125

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	10,125	0.0%	152,507	12/31/2025
2025 Q3	11/13/2025	2,767	0.0%	80,235	9/30/2025
2025 Q2	8/14/2025	1,080	0.0%	68,374	6/30/2025
2025 Q1	5/13/2025	858	0.0%	67,340	3/31/2025
2024 Q4	2/13/2025	1,182	0.0%	62,886	12/31/2024
2024 Q3	11/13/2024	851	0.0%	43,953	9/30/2024
2024 Q2	8/13/2024	1,208	0.0%	46,471	6/30/2024
2024 Q1	5/10/2024	1,291	0.0%	45,132	3/31/2024
2023 Q4	2/9/2024	1,601	0.0%	52,315	12/31/2023
2023 Q3	11/13/2023	2,804	0.0%	104,337	9/30/2023
2023 Q2	8/15/2023	3,924	0.0%	110,050	6/30/2023
2023 Q1	5/12/2023	2,683	0.0%	105,636	3/31/2023
2022 Q4	2/13/2023	6,301	0.0%	155,353	12/31/2022
2022 Q3	11/14/2022	5,360	0.0%	162,171	9/30/2022
2022 Q2	8/12/2022	5,311	0.0%	150,808	6/30/2022
2022 Q1	5/16/2022	8,888	0.0%	193,271	3/31/2022
2021 Q4	2/14/2022	14,154	0.0%	213,489	12/31/2021
2021 Q3	11/15/2021	13,454	0.0%	215,512	9/30/2021
2021 Q2	8/16/2021	18,650	0.0%	225,192	6/30/2021
2021 Q1	5/13/2021	16,752	0.0%	252,640	3/31/2021
2020 Q4	2/9/2021	20,475	0.0%	266,840	12/31/2020
2020 Q3	11/5/2020	10,158	0.0%	235,895	9/30/2020
2020 Q2	8/13/2020	11,251	0.0%	260,480	6/30/2020
2020 Q1	5/14/2020	6,529	0.0%	226,937	3/31/2020
2019 Q4	2/14/2020	14,857	0.0%	234,225	12/31/2019